| Name | Title | Contact Details |
|---|
Changing lives with next generation peptide therapeutics
Mavupharma is developing non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.
Meta Systems is a Waltham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Accelerator Life Science Partners catalyzes the development and commercialization of breakthrough biotechnology innovations.
Also known as Advantagene. Inc., we are a Massachusetts-based biotechnology company developing our proprietary immuno-oncology platforms for the treatment of solid tumors, including our Gene Mediated Cytotoxic (GMCI™) platform and our rQNestin34.5 platform. GMCI™ is an "off-the-shelf" immunotherapy designed to generate a personalized, robust, and precise systemic response from the patient's own immune system against his or her cancer.